Navigation Links
Questcor Pharmaceuticals Responds to Questions From Investor Blog
Date:1/16/2012

n patients who might be candidates for being treated with Acthar."

5. How much did Questcor originally pay for the rights to Acthar?

Questcor Response:  Questcor rescued Acthar in 2001 after it was abandoned by a large, internationally recognized pharmaceutical company. This other company notified the FDA of their plans to discontinue the manufacture of Acthar due in great measure to the difficulty and expense of the manufacturing and production process. Questcor stepped in and purchased all worldwide rights to Acthar for a nominal price and for a continuing royalty on future net sales. In addition to the purchase price paid at the closing of the transaction, and as was expected at the time of the purchase, Questcor has invested millions of dollars in transferring and improving the manufacturing process, which was necessary in order to continue production and sale of Acthar.

6. How much does Questcor charge for a vial of the drug today?

Questcor Response:  Questcor sells Acthar to its distributor for approximately $27,000 per vial.  The Company is committed to providing access to Acthar to patients who need it, through our support of the Acthar patient assistance programs administered by the National Organization of Rare Disorders as well as by providing Acthar free-of-charge to Childrens' Hospitals throughout the US. Through our support, these and other important patient-oriented support programs have now provided Acthar with a commercial value of over $124 million at no charge to patients since September 2007.

7. Can analysts/investors utilize the popular IMS database to track Acthar prescription trends? If not, when did this change and why?

Questcor Response:  The IMS database service is one of several third-party services that track some pharmaceutical prescription trends.  Questcor is not responsible for the accuracy of the information provided by any of these servic
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Questcor Pharmaceuticals Issues Statement
2. Questcor Pharmaceuticals Reports Strong Finish to 2011
3. Questcor Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference on November 30, 2011
4. Questcor Pharmaceuticals to Present at CLSAs 4th Annual AsiaUSA Forum on November 7, 2011
5. Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week
6. Questcor Reports Third Quarter Financial Results
7. Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011
8. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
9. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
10. Questcor Provides Updated New Paid Prescription Trends
11. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the Morgan ... at 10:20 a.m. ET. The conference will be held ... New York City . About Abaxis ...
(Date:9/2/2014)...  Hologic, Inc. (NASDAQ: HOLX ) today announced ... will present at the Morgan Stanley Global Healthcare Conference in ... York on Tuesday, September 9, 2014 at 12:20 ... listen to the live audio webcast of the presentation on ... An archive of the presentation will be available for replay ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014  Arena ... that the US Food and Drug Administration (FDA) has ... of pulmonary arterial hypertension. "The FDA ... clinical data submissions from sponsors to identify and designate ... help advance the evaluation and development of such products," ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4
... ARLINGTON HEIGHTS, Ill., Sept. 12 Even as,many ... available today,we are stopped by our rear reflection and ... study published in the October issue of Plastic and,Reconstructive ... Plastic Surgeons (ASPS), reveals a new back lift procedure ...
... Ala., Sept. 11 - Southern,Research Institute and ... from a study testing Naltrexone-derived,pyridomorphinan (SoRI-9409) will ... of,the journal Biological Psychiatry. The publication is ... suggests that a new compound that,causes selective ...
Cached Medicine Technology:Say 'Goodbye' to Back Fat Rolls 2Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4
(Date:9/2/2014)... Healthcare professionals will be able to access ... available at the point of care following an agreement ... Comprehensive Cancer Network® (NCCN®). Information from NCCN will ... the content available from the clinical reference tool ... of 25 of the world's leading cancer centers devoted ...
(Date:9/2/2014)... from cancer surgery may be influenced by more ... Family conflicts and other non-medical problems may raise ... study has found. Addressing such quality-of-life issues before ... recoveries and save health care dollars, the research ... patients, and found that patients with a poor ...
(Date:9/2/2014)... the key to more youthful immune function might already ... in the Journal of Leukocyte Biology ... old mice had different responses to Mycobacterium tuberculosis ... were reversed by ibuprofen. , "Inflammation in old age ... Turner, Ph.D., a researcher involved in the work from ...
(Date:9/2/2014)... According to a new report by ... authority in medical device market research, the ... grow to over €2 billion in 2020. Growth ... number of procedures for the treatment of BPH, ... TURP devices, laser BPH devices, brachytherapy, urinary catheters, ...
(Date:9/2/2014)... New York (PRWEB) September 02, 2014 ... application of nanotechnology in diagnosing, treating and/or prevention ... are applied for treating cardiovascular, neurological, and oncology ... utilization of knowledge pertaining to various nanoparticles, their ... body., There still exists considerable scope for research ...
Breaking Medicine News(10 mins):Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 3Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3
... /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: MR ... devices worldwide, today announced the company and,its employees ... million,through the Red Cross Society of China to ... Mr. Xu Hang and Mr. Li Xiting,Mindray,s co-chief ...
... alternative,medicine is a diverse group of health care ... traditional medicine. According to the U.S.,Department of Health ... and alternative medicine, which includes dietary supplements., ... of dietary supplements has grown considerably in the ...
... Hopkins undergraduates have designed and built a device to ... their beds and walk while remaining tethered to essential ... whether carefully supervised rehabilitation, as opposed to continuous sedation ... care patients. , Some clinicians believe that allowing ICU ...
... LONDON, May 29 More northern women feel bloating ... of them likely to,experience it at any one time, ... from the West Midlands and Yorkshire and Humberside fared ... experiencing the least,amount of bloated feelings. And 61% of ...
... youth smoking uptake greatly reduced if parents quit, LONDON, ... research shows that a child,s odds of daily smoking are,reduced ... continue,to smoke. And if both parents were smokers but quit, ... shows that mothers who,quit are less likely to have children ...
... The following is a,statement of Matthew L. Myers, ... Sheila Dixon and Baltimore City Health Department,Commissioner Dr. ... protect,the city,s children and health by proposing a ... The proliferation of individually sold cigars in ...
Cached Medicine News:Health News:Mindray Donates Cash and Equipment for Sichuan Earthquake Relief 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: The Impact of Diet and Supplements on Health 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: The Impact of Diet and Supplements on Health 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: The Impact of Diet and Supplements on Health 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: The Impact of Diet and Supplements on Health 5Health News:Figure Skater Peggy Fleming Teams With HealthSaver: The Impact of Diet and Supplements on Health 6Health News:Students' device allows ICU patients to get back on their feet 2Health News:Students' device allows ICU patients to get back on their feet 3Health News:North South Divide Exists in UK Digestive Health 2Health News:North South Divide Exists in UK Digestive Health 3Health News:Parents: Quit Smoking and Your Children Are Less Likely to Smoke 2Health News:Parents: Quit Smoking and Your Children Are Less Likely to Smoke 3Health News:Parents: Quit Smoking and Your Children Are Less Likely to Smoke 4Health News:Baltimore's Proposed Ban on Sale of Single, Cheap Cigars Would Protect Kids and Health 2
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Ultra HDL (UHDL) assay is used for the quantitation of high density lipoprotein (HDL) cholesterol in human serum or plasma....
... A histological embedment block ... This file system incorporates ... embedment block protection, simplified ... error and facilitation of ...
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: